Anhui New Peak North Carolina was established in July
Release time:
2020-08-21
Anhui Zhongwang and Jianfeng North Card Merger and Reorganization
Anhui New Jianfeng North Card was established in March
News from our newspaper After several months of integration and adjustment, Anhui Zhongwang Pharmaceutical Co., Ltd. and Anhui Jianfeng North Card Pharmaceutical Co., Ltd., two subsidiaries of Shanghai Beika Pharmaceutical Technology Co., Ltd., completed the reorganization and merger in September 7, established "Anhui New Peak North Card Pharmaceutical Co., Ltd".
The newly established New Jianfeng Beika Pharmaceutical Co., Ltd. is located in Anhui Dongzhe Economic Development Zone, covering an area of 280mu, with a registered capital of RMB 1.2 .5 billion yuan and a total investment of RMB 3 .7 billion yuan. It is a high-tech and innovative enterprise integrating R & D, production and sales, the main products include small molecule targeted generic drugs, cytotoxic and highly active products, quinolone anti-infective drug platforms, specialty varieties and advanced intermediates, etc. At the same time, the contract custom production CDMO mode has also entered the substantive operation stage. The company implements strict GMP standard management and product quality control, and has passed ISO9001 , 14001 , OHSAS18000 certification, and established Chizhou Enterprise Technology Research and Development Center. And in 2019 years 11 January to obtain a pharmaceutical production license.
In terms of product research and technology research, New Jianfeng North Carolina Pharmaceutical relies on the research and development team and academician expert workstations of Shanghai North Carolina, and has also established long-term industry-university-research cooperation with scientific research institutions such as Chinese Academy of Sciences, China Pharmaceutical University, Fudan University, Shanghai Engineering Research Center for Molecular Therapy and New Drug Creation, and is equipped with complete synthesis laboratories and analysis laboratories, the main research and development equipment can meet the research and development and production of grams to 100 kilograms. In terms of safety and environmental protection management, a large amount of money has been invested in the sewage treatment station in the plant area, and full-time safety management personnel have been equipped to establish a three-level safety management system.After the integration of Anhui New Jianfeng North Card Pharmaceutical Co., Ltd. will continue to undertake the second batch of major emerging industrial projects of "Triple and One Innovation" in Anhui Province. On the basis of the original 2
workshops and1 GMP pilot workshops, the second phase project of adding 3 GMP workshops and 3 advanced pharmaceutical intermediate workshops is also under construction, actively cooperating with domestic pharmaceutical preparation enterprises to jointly build a green pharmaceutical platform, enabling more CDMO/CMO development. (Zhang Yang Lina)
More information
The company's vocational skill level independently identifies two new occupations
A few days ago, after the examination and approval of the Jinhua Municipal Bureau of Human Resources and Social Security, and reported to the Provincial Department of Human Resources and Social Security for examination and filing, Jianfeng Group's independent identification level of vocational skills was based on last year. Two new occupations (types of work) are chemical inspectors and organic synthesis workers.
2022
05-20
On May 12, Cai Xiaochun, deputy secretary of the Party group of Zhejiang Federation of industry and commerce, and his party visited Jianfeng group for investigation, visited Jinxi factory area of Jianfeng pharmaceutical factory and Jinxi internationalization project site, and had a discussion with Jiang Xiaomeng, chairman of the group company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company.
2022
05-20
On the afternoon of April 6, Jiang Xiaomeng, chairman of the group company, was invited to participate in the Jinhua News Client Financial Media Interview column "Night Talk of the Two Sessions", as a representative of the Jinhua Municipal People's Congress, to talk about suggestions for the future development of Jinhua enterprises. As the chairman of the Jinhua City Federation of Industry and Commerce, Jiang Xiaomeng has a personal experience of various problems encountered in the development of Jinhua enterprises. After careful investigation and full preparation, he put forward two proposals on strengthening the empowerment and allocation of production factors and further enhancing the market competitiveness of enterprises in our city and further promoting the compliance construction of private enterprises in our city and reducing the risk of enterprise operation. In the "two sessions night talk" interview, he put forward his own views on these two topics.
2022
04-12
Group Companies Commend 2021 Advanced
On the morning of January 26, the group company held the 2021 annual summary commendation meeting to review the work of the previous year, make arrangements for the work of 2022, sign the 2022 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2021 advanced collectives and individuals.
2022
02-08
Group Company Convenes Workers' Representative and Trade Union Member Representative Conference
The group company held a representative meeting of staff representatives and trade union members, elected members of the eighth trade union committee and members of various special committees, and Shi Fu was elected chairman of the eighth trade union of the group trade union.
2022
02-08
The group company held an annual safety and environmental protection work conference to comprehensively summarize and review the safety and environmental protection work in 2021, make arrangements for the safety and environmental protection work in 2022, and sign the safety and environmental protection work responsibility system.
2022
02-08